A Specific Interferon (IFN)-stimulated Response Element of the Distal HLA-G Promoter Binds IFN-regulatory Factor 1 and Mediates Enhancement of This Nonclassical Class I Gene by IFN-β
about
Trophoblast 'pseudo-tumorigenesis': significance and contributory factorsSome basic aspects of HLA-G biologyThe dual role of HLA-G in cancerImmunomodulatory properties of HLA-G in infectious diseasesTranscriptional and posttranscriptional regulations of the HLA-G geneSoluble HLA-G protein secreted by allo-specific CD4+ T cells suppresses the allo-proliferative response: a CD4+ T cell regulatory mechanism.HLA-G gene repression is reversed by demethylationNon-classical transcriptional regulation of HLA-G: an update.The role of HLA-G in immunity and hematopoiesis.HLA-G as a tolerogenic molecule in transplantation and pregnancy.Impact of HLA-G analysis in prevention, diagnosis and treatment of pathological conditionsA comprehensive study of polymorphic sites along the HLA-G gene: implication for gene regulation and evolution.Implications of the polymorphism of HLA-G on its function, regulation, evolution and disease association.Biology of HLA-G in cancer: a candidate molecule for therapeutic intervention?Clinical and biological significance of HLA-G expression in ovarian cancerNon-classical HLA-G antigen and its role in the cancer progression.Human leukocyte antigen-G expression in differentiated human airway epithelial cells: lack of modulation by Th2-associated cytokines.Major histocompatibility complex class I core promoter elements are not essential for transcription in vivo.Hypoxia inducible factor-1 mediates the expression of the immune checkpoint HLA-G in glioma cells through hypoxia response element located in exon 2.The importance of HLA-G expression in embryos, trophoblast cells, and embryonic stem cells.HLA-G expression in hematologic malignancies.HLA-G in organ transplantation: towards clinical applications.HLA-G regulators in cancer medicine: an outline of key requirements.The immunosuppressive molecule HLA-G and its clinical implications.IL-27 driven upregulation of surface HLA-E expression on monocytes inhibits IFN-γ release by autologous NK cells.Osteodifferentiated mesenchymal stem cells from bone marrow and adipose tissue express HLA-G and display immunomodulatory properties in HLA-mismatched settings: implications in bone repair therapy.Soluble HLA-G molecules increase during acute leukemia, especially in subtypes affecting monocytic and lymphoid lineages.Alloreactive CD4+ and CD8+ T cells express the immunotolerant HLA-G molecule in mixed lymphocyte reactions: in vivo implications in transplanted patients.In vivo, RFX5 binds differently to the human leucocyte antigen-E, -F, and -G gene promoters and participates in HLA class I protein expression in a cell type-dependent manner.The non-classical MHC molecule HLA-G protects human muscle cells from immune-mediated lysis: implications for myoblast transplantation and gene therapy.Modulation of HLA-G expression in human neural cells after neurotropic viral infectionsAltered pattern of major histocompatibility complex expression in renal carcinoma: tumor-specific expression of the nonclassical human leukocyte antigen-G molecule is restricted to clear cell carcinoma while up-regulation of other major histocompatiInterferon activates promoter of Nmi gene via interferon regulator factor-1.Revealing global regulatory perturbations across human cancers.Balancing immunity and tolerance: genetic footprint of natural selection in the transcriptional regulatory region of HLA-G.The miscarriage-associated HLA-G -725G allele influences transcription rates in JEG-3 cells.The genetic diversity within the 1.4 kb HLA-G 5' upstream regulatory region moderately impacts on cellular microenvironment responses.Expression of the immune-tolerogenic major histocompatibility molecule HLA-G in multiple sclerosis: implications for CNS immunity.A Positive Feedback Amplifier Circuit That Regulates Interferon (IFN)-Stimulated Gene Expression and Controls Type I and Type II IFN Responses.HLA-G gene polymorphisms associated with susceptibility to rheumatoid arthritis disease and its severity in Brazilian patients
P2860
Q24798593-6C160879-7A6E-49F8-9A2F-7474A82AA134Q26852671-D661A8C9-8536-4FEE-BC9B-FD348D139692Q26860886-78D75960-87F2-442C-9B19-845976716769Q27013645-EBBACB44-242C-4139-B80D-663B611D1767Q27015092-C69A7376-B5AF-416C-9C74-AB77B38D83B1Q33947063-0A7BDC6F-8B1F-494D-9CAE-4E02CDBABBF3Q33963997-4814FD18-315F-4264-87B1-1F51516CA6DAQ34017943-85E6DE41-765D-410A-9DA2-8C0C771487ACQ34024865-97D32E90-4CA9-4984-A263-CC4CBD6E91D9Q34038019-BC86B253-4C0C-4D03-96E0-D45C08561F7CQ34093041-442744D4-4982-43D5-A4A2-5C67E52CCF17Q34188250-E4603883-05BC-4F1A-B312-34BF69720E97Q34491478-8164E63F-9C29-464A-AB95-48A19A91CC8FQ36184793-466CF4E4-C1B4-4AD6-85B4-7F4778737E58Q36296442-BB3589BD-26DC-4601-A513-AB8E60DA60E9Q36421272-0A943025-05E8-49FD-A7B9-7B3F68E8C54BQ36575385-5806606B-B8E2-45F2-9BDB-C51BFB2A4B43Q37336572-AF3EEF45-E059-4B89-825A-7CADA65371F0Q37665438-6004022F-D656-4DE1-A762-59BA9E284613Q37809765-F9BAF275-7950-4188-BCAE-FF0FFE6D5CA6Q37810072-223A902A-A48B-441D-901D-D527B79BED95Q37811950-B79F85AE-F0A1-4030-A7CD-BB0AA1CC01FAQ37906387-188CAB8A-F39D-42CD-800C-5CA48231CD2BQ38005743-0C0DA858-5367-4C7A-A278-8B4C85A6C950Q38772289-E2B5538A-CB34-47C5-B25C-41D6A596B036Q39642763-48D34288-5019-478F-A5A3-407CE5950745Q40293176-A145EC9A-D2E4-4F06-AD03-377723242E65Q40584279-6F88E3DF-3F12-4402-943D-FEF49EE02B48Q40607018-3268A7A5-5F21-40FC-8BFB-07BF8226021FQ40616181-89A7362E-B6B3-4193-8BCE-D36971856FB5Q40669869-E3528508-67D4-4FC7-9D28-51FB00CD278FQ42147337-89FCC406-135B-469A-92E6-15CF3A1F95B1Q42515124-2315A5C6-C6FA-4B54-B4EC-55EB55DEC62AQ42736171-D7F9F115-3122-4F53-A9AA-D62E38D06D51Q46598900-6EE7176D-D003-4251-9006-2F45A367B680Q46963129-152FFE4D-2A36-44DD-8316-0F698C09EA03Q52721502-E4B70213-34D3-4D8D-9200-8326732C6AD3Q53271841-A46D0D51-77FA-4F49-A779-0810F2EBCDCAQ54976472-86D42B27-F774-4483-8C3D-83ED6158BCA4Q57200140-281E054A-8A54-4FE9-A426-103ADCA54D09
P2860
A Specific Interferon (IFN)-stimulated Response Element of the Distal HLA-G Promoter Binds IFN-regulatory Factor 1 and Mediates Enhancement of This Nonclassical Class I Gene by IFN-β
description
article publié dans la revue scientifique Journal of Biological Chemistry
@fr
im November 2000 veröffentlichter wissenschaftlicher Artikel
@de
scientific article published in Journal of Biological Chemistry
@en
wetenschappelijk artikel
@nl
наукова стаття, опублікована в листопаді 2000
@uk
name
A Specific Interferon (IFN)-st ...... lassical Class I Gene by IFN-β
@en
A Specific Interferon
@nl
type
label
A Specific Interferon (IFN)-st ...... lassical Class I Gene by IFN-β
@en
A Specific Interferon
@nl
prefLabel
A Specific Interferon (IFN)-st ...... lassical Class I Gene by IFN-β
@en
A Specific Interferon
@nl
P2093
P2860
P356
P1476
A specific interferon (IFN)-st ...... sical class I gene by IFN-beta
@en
P2093
Carosella ED
Lefebvre S
P2860
P304
P356
10.1074/JBC.M008496200
P407
P577
2000-11-21T00:00:00Z